Latest filing published 24 Jun 2026 for Evommune, Inc.. Read the official filing
No signal scores available.
This profile gathers the share dealings of Janice Suzann Drew in Evommune, Inc. We count 5 filings; the first trade dates from 7 November 2025 and the latest from 22 June 2026.
On the market, this insider has only sold: 1 sale. No amount is published for 1 filing, which the totals therefore leave out. Outside the open market, there are 1 share grant and 2 option exercises. Since January 2026: no purchases and 1 sale on the market.
The latest filing, published on 24 June 2026, reports an option exercise in Evommune, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations